Asymmetric dimethylarginine levels and diabetes duration: Relationship with measures of subclinical atherosclerosis and cardiac function in children and adolescents with Type 1 diabetes

Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease
Betül ErsoyŞenol Coşkun

Abstract

We aimed to evaluate asymmetric dimethylarginine levels in young patients with Type 1 diabetes mellitus according to diabetes duration and to examine the relationship between these levels and measures of atherosclerosis and myocardial function. In total, 83 patients (8.5-22 years) with Type 1 diabetes mellitus were stratified by diabetes duration: 12-60 months (Group 1, n = 27), >60-120 months (Group 2, n = 29) and >120 months (Group 3, n = 27). Asymmetric dimethylarginine levels were assessed. Carotid intima-media thickness was measured. Myocardial function was assessed by M-mode, conventional Doppler and tissue Doppler echocardiography. Asymmetric dimethylarginine level was significantly higher in Group 1, while carotid intima-media thickness was significantly greater in Group 3 ( p < 0.05). Tissue Doppler echocardiography showed the ratio of peak early to peak late diastolic myocardial annular velocity decreased significantly in Groups 2 and 3 with a negative correlation with duration (r: -0.310, p = 0.004) and HBA1c levels (r = -0.391, p < 0.001). Myocardial performance index in all groups and isovolumic relaxation time in Group 3 increased significantly. Asymmetric dimethylarginine levels were negatively correlated with ca...Continue Reading

Associated Clinical Trials

References

Sep 1, 1989·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·N B SchillerI Schnittger
Jun 30, 1988·Biochemical and Biophysical Research Communications·R M PalmerS Moncada
Feb 25, 2003·Journal of the American College of Cardiology·Tajinder P SinghAndris Kazmers
Aug 6, 2004·Endocrine Reviews·Zhi You FangThomas H Marwick
Jan 8, 2005·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Toshinori YuasaChuwa Tei
Aug 3, 2005·International Journal of Cardiology·Matthew A AllisonC Michael Wright
Apr 22, 2006·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Antonio Ceriello
Sep 5, 2006·Journal of Diabetes and Its Complications·Larry A DistillerGreg B Distiller
Feb 22, 2007·The Journal of Clinical Endocrinology and Metabolism·Alev E AltinovaFusun B Toruner
Oct 3, 2008·Scandinavian Journal of Clinical and Laboratory Investigation·Kaire HeilmanVallo Tillmann
May 12, 2009·The American Journal of Cardiology·Aaron M FromHorng H Chen
Mar 27, 2010·Korean Circulation Journal·Eun Ha Kim, Yeo Hyang Kim
Feb 8, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·M L MarcovecchioR N Dalton
May 10, 2011·Nitric Oxide : Biology and Chemistry·A L SverdlovJ D Horowitz
Oct 30, 2013·Cardiovascular Diabetology·Oliver SchnellAntonio Ceriello
Nov 7, 2013·International Journal of Molecular Sciences·Aleksandra Jaźwińska-KozubaStefanie M Bode-Böger
Oct 12, 2014·Pediatric Cardiology·Ahmed Anwer Khattab, Mahmoud Ali Soliman
Sep 23, 2016·Journal of Pediatric Endocrinology & Metabolism : JPEM·Robert P HoffmanJohn A Bauer

❮ Previous
Next ❯

Citations

Jan 22, 2021·The International Journal of Cardiovascular Imaging·Nino Emanuel LandlerTor Biering-Sørensen
Aug 13, 2021·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·Maria Felicia FaienzaMarco Matteo Ciccone

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent method

Software Mentioned

SPSS

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.